We thought QC6352 and zavondemstat worked as KDM4 inhibitors. Our new glioblastoma study shows their antitumour activity is actually driven by DHODH inhibition. I contributed to the preclinical therapeutic studies. #HGG #KDM4 www.nature.com/articles/s41...